Targeting myofibroblastic cancer-associated fibroblasts (myCAFs): a promising strategy for overcoming tumor progression and immunotherapy resistanceDanting Wang and Zhigang ChenVis Cancer Med, 6 (2025) 4DOI: https://doi.org/10.1051/vcm/2025005
